Side-by-side financials for EOLS and MRK. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EOLS | MRK |
|---|---|---|
| Market cap | - | $295.68 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $297.18M | $65.01B |
| Net income (latest FY) | -$51.64M | $18.25B |
| Net margin | -17.4% | 28.1% |
| P/E (trailing FY) | - | 16.2 |
| SEC filings | 543 | 996 |
In their latest fiscal years, Evolus, Inc. reported $297.18M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Evolus, Inc. and Merck & Co., Inc., or browse the full rankings.